These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25251901)

  • 1. Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
    von Scholten BJ; Lajer M; Goetze JP; Persson F; Rossing P
    Diabet Med; 2015 Mar; 32(3):343-52. PubMed ID: 25251901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes.
    von Scholten BJ; Hansen TW; Goetze JP; Persson F; Rossing P
    J Diabetes Complications; 2015 Jul; 29(5):670-4. PubMed ID: 25935863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
    Kumarathurai P; Anholm C; Fabricius-Bjerre A; Nielsen OW; Kristiansen O; Madsbad S; Haugaard SB; Sajadieh A
    J Hypertens; 2017 May; 35(5):1070-1078. PubMed ID: 28129251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
    Skov J; Pedersen M; Holst JJ; Madsen B; Goetze JP; Rittig S; Jonassen T; Frøkiaer J; Dejgaard A; Christiansen JS
    Diabetes Obes Metab; 2016 Jun; 18(6):581-9. PubMed ID: 26910107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.
    von Scholten BJ; Persson F; Rosenlund S; Eugen-Olsen J; Pielak T; Faber J; Hansen TW; Rossing P
    Diabetes Obes Metab; 2017 Jun; 19(6):901-905. PubMed ID: 28105731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
    Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ
    Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.
    Fonseca VA; Devries JH; Henry RR; Donsmark M; Thomsen HF; Plutzky J
    J Diabetes Complications; 2014; 28(3):399-405. PubMed ID: 24561125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment.
    Zobel EH; von Scholten BJ; Lindhardt M; Persson F; Hansen TW; Rossing P
    J Diabetes Complications; 2017 Jan; 31(1):162-168. PubMed ID: 27769801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of liraglutide on renal function: A randomized clinical trial.
    von Scholten BJ; Persson F; Rosenlund S; Hovind P; Faber J; Hansen TW; Rossing P
    Diabetes Obes Metab; 2017 Feb; 19(2):239-247. PubMed ID: 27753201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.
    Faber R; Zander M; Pena A; Michelsen MM; Mygind ND; Prescott E
    Cardiovasc Diabetol; 2015 Apr; 14():41. PubMed ID: 25896352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
    Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of up-titration of candesartan versus candesartan plus amlodipine on kidney function in type 2 diabetic patients with albuminuria.
    Okura T; Kojima M; Machida H; Sugiyama M; Kato T; Komada T; Miyazaki T; Ninomiya T; Ichikawa T; Nakatani K; Watanabe Y; Dohi Y; Ito M; Kimura G
    J Hum Hypertens; 2012 Apr; 26(4):214-9. PubMed ID: 21412266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients.
    Weir MR; Hollenberg NK; Remuzzi G; Zappe DH; Meng X; Parving HH
    J Hypertens; 2011 Oct; 29(10):2031-7. PubMed ID: 21841500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials.
    Zhao X; Huang K; Zheng M; Duan J
    BMC Endocr Disord; 2019 Jan; 19(1):4. PubMed ID: 30616638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.